Can early gut microbiota screening reduce the incidence of cognitive impairment? A Mendelian randomization study
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-231457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Chongcheng Xi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Gastrointestinal Microbiome, Cognitive Dysfunction, Genome-Wide Association Study. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: the Fundamental Research Funds for the Central Universities, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Background
Gastrointestinal symptoms are now detected early in the clinical course of many dementia patients, and studies of the microbiome-gut-brain axis have confirmed bidirectional interactions between the gut and the brain. However, the causal relationship between gut microbiota and cognitive impairment has not been fully established. Therefore, this study conducted a bidirectional Mendelian randomization study to elucidate the potential causal relationship of gut microbiota to cognitive impairment.
Objective
Using Mendelian randomization to identify gut flora with a genetic causal effect on the development of cognitive impairment.
Methods
This study utilized publicly available genome-wide association study summary data to perform MR analysis, with gut microbiota as the exposure and various cognitive function indicators as well as scores for Alzheimer's disease as outcomes. This study selected single nucleotide polymorphisms as instrumental variables based on p-values, F-statistics, and r 2 . Bidirectional Mendelian randomization was conducted using methods such as inverse variance weighted, MR-Egger, simple mode, and weighted mode to assess the causal relationship. Concurrently, this study carried out Cochran's Q test, MR-Egger intercept test, and leave-one-out analysis to identify potential heterogeneity and horizontal pleiotropy.
Results
This study identified a total of 31 gut microbes that have a causal relationship with cognitive impairment, which include 1 phylum, 4 classes, 3 orders, 2 families, and 21 genera.
Conclusions
This study unveiled specific gut microbiota associated with cognitive impairment, offering new insights and approaches for the prevention and treatment of cognitive impairment through gut microbiota such as Bifidobacterium and Ruminococcus gnavus group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Förderung
- the Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Xi, C., Zhang, J., Liu, H., Xing, J., Ding, Y., Wei, W., Wang, L., & Liu, Z. (2024). Can early gut microbiota screening reduce the incidence of cognitive impairment? A Mendelian randomization study. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-231457
Vancouver
Xi C, Zhang J, Liu H, Xing J, Ding Y, Wei W, et al. Can early gut microbiota screening reduce the incidence of cognitive impairment? A Mendelian randomization study. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-231457
BibTeX
@article{Xi2024,
author = {Xi, Chongcheng and Zhang, Jie and Liu, Haihui and Xing, Jia and Ding, Yiyun and Wei, Wei and Wang, Le and Liu, Zhenzhu},
title = {Can early gut microbiota screening reduce the incidence of cognitive impairment? A Mendelian randomization study},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-231457}
}
EUVIMED